Recent treatments of interstitial lung disease with systemic sclerosis

Hidekata Yasuoka

doi:10.4137/CCRPM.S23315

Recent treatments of interstitial lung disease with systemic sclerosis

Hidekata Yasuoka

Research output: Contribution to journal › Article

11 Citations (Scopus)

Abstract

Systemic sclerosis (SSc) is a disorder characterized by immune dysfunction, microvascular injury, and fibrosis. Organ involvement in patients with SSc is variable; however, pulmonary involvement occurs in up to 90% of patients with SSc. Interstitial lung disease (ILD) is a major cause of mortality and, thus, a major determinant in the prognosis of patients with SSc. This review summarizes current findings about the characteristics of ILD in patients with SSc, selection of patients with SSc-ILD who are candidates for the treatment, and current treatment options.

Original language	English
Pages (from-to)	97-110
Number of pages	14
Journal	Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine
Volume	9
DOIs	https://doi.org/10.4137/CCRPM.S23315
Publication status	Published - 19-01-2016
Externally published	Yes

All Science Journal Classification (ASJC) codes

Pulmonary and Respiratory Medicine
Cardiology and Cardiovascular Medicine

Access to Document

10.4137/CCRPM.S23315

Fingerprint Dive into the research topics of 'Recent treatments of interstitial lung disease with systemic sclerosis'. Together they form a unique fingerprint.

Cite this

Yasuoka, H. (2016). Recent treatments of interstitial lung disease with systemic sclerosis. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 9, 97-110. https://doi.org/10.4137/CCRPM.S23315

@article{2064a79aaeb94bbca96e8f1126d86803,

title = "Recent treatments of interstitial lung disease with systemic sclerosis",

abstract = "Systemic sclerosis (SSc) is a disorder characterized by immune dysfunction, microvascular injury, and fibrosis. Organ involvement in patients with SSc is variable; however, pulmonary involvement occurs in up to 90% of patients with SSc. Interstitial lung disease (ILD) is a major cause of mortality and, thus, a major determinant in the prognosis of patients with SSc. This review summarizes current findings about the characteristics of ILD in patients with SSc, selection of patients with SSc-ILD who are candidates for the treatment, and current treatment options.",

author = "Hidekata Yasuoka",

year = "2016",

month = jan,

day = "19",

doi = "10.4137/CCRPM.S23315",

language = "English",

volume = "9",

pages = "97--110",

journal = "Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine",

issn = "1179-5484",

publisher = "Libertas Academica Ltd.",

}

TY - JOUR

T1 - Recent treatments of interstitial lung disease with systemic sclerosis

AU - Yasuoka, Hidekata

PY - 2016/1/19

Y1 - 2016/1/19

N2 - Systemic sclerosis (SSc) is a disorder characterized by immune dysfunction, microvascular injury, and fibrosis. Organ involvement in patients with SSc is variable; however, pulmonary involvement occurs in up to 90% of patients with SSc. Interstitial lung disease (ILD) is a major cause of mortality and, thus, a major determinant in the prognosis of patients with SSc. This review summarizes current findings about the characteristics of ILD in patients with SSc, selection of patients with SSc-ILD who are candidates for the treatment, and current treatment options.

AB - Systemic sclerosis (SSc) is a disorder characterized by immune dysfunction, microvascular injury, and fibrosis. Organ involvement in patients with SSc is variable; however, pulmonary involvement occurs in up to 90% of patients with SSc. Interstitial lung disease (ILD) is a major cause of mortality and, thus, a major determinant in the prognosis of patients with SSc. This review summarizes current findings about the characteristics of ILD in patients with SSc, selection of patients with SSc-ILD who are candidates for the treatment, and current treatment options.

UR - http://www.scopus.com/inward/record.url?scp=84960345465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960345465&partnerID=8YFLogxK

U2 - 10.4137/CCRPM.S23315

DO - 10.4137/CCRPM.S23315

M3 - Article

AN - SCOPUS:84960345465

VL - 9

SP - 97

EP - 110

JO - Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine

JF - Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine

SN - 1179-5484

ER -